Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Cirrhosis, Biliary | 8 | 2024 | 108 | 1.420 |
Why?
|
Liver Cirrhosis | 11 | 2022 | 1962 | 1.060 |
Why?
|
Hepatitis, Autoimmune | 6 | 2023 | 173 | 1.010 |
Why?
|
Ammonia | 2 | 2016 | 248 | 0.940 |
Why?
|
Ceftriaxone | 1 | 2019 | 175 | 0.590 |
Why?
|
Hepatic Encephalopathy | 2 | 2015 | 144 | 0.550 |
Why?
|
Peritonitis | 1 | 2019 | 368 | 0.540 |
Why?
|
Stomach Diseases | 2 | 2015 | 134 | 0.530 |
Why?
|
Transaminases | 1 | 2017 | 199 | 0.530 |
Why?
|
Quinolones | 1 | 2019 | 389 | 0.500 |
Why?
|
Gastric Antral Vascular Ectasia | 1 | 2014 | 6 | 0.470 |
Why?
|
Hyperammonemia | 1 | 2015 | 80 | 0.460 |
Why?
|
Nucleosides | 1 | 2014 | 131 | 0.450 |
Why?
|
Liver Transplantation | 4 | 2023 | 2403 | 0.420 |
Why?
|
Hypertension, Portal | 1 | 2014 | 230 | 0.390 |
Why?
|
Nucleotides | 1 | 2014 | 455 | 0.390 |
Why?
|
Gastroenterology | 2 | 2016 | 593 | 0.380 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1063 | 0.380 |
Why?
|
Gastrointestinal Hemorrhage | 5 | 2017 | 1126 | 0.370 |
Why?
|
Enteral Nutrition | 1 | 2017 | 802 | 0.360 |
Why?
|
Bacterial Infections | 1 | 2019 | 1397 | 0.360 |
Why?
|
Cholangitis | 2 | 2023 | 110 | 0.340 |
Why?
|
Cholangitis, Sclerosing | 3 | 2023 | 179 | 0.340 |
Why?
|
Hepatitis B, Chronic | 1 | 2014 | 413 | 0.340 |
Why?
|
Receptors, Aryl Hydrocarbon | 2 | 2023 | 221 | 0.340 |
Why?
|
Patient Admission | 2 | 2016 | 1370 | 0.330 |
Why?
|
Ursodeoxycholic Acid | 3 | 2024 | 81 | 0.330 |
Why?
|
Hepacivirus | 2 | 2015 | 1344 | 0.310 |
Why?
|
Anorexia Nervosa | 1 | 2017 | 1364 | 0.290 |
Why?
|
End Stage Liver Disease | 2 | 2022 | 370 | 0.290 |
Why?
|
Colonoscopy | 1 | 2016 | 1410 | 0.290 |
Why?
|
Muscle Cramp | 2 | 2024 | 33 | 0.290 |
Why?
|
Hepatitis C | 2 | 2015 | 1595 | 0.280 |
Why?
|
Liver Diseases | 3 | 2022 | 1305 | 0.270 |
Why?
|
Liver Function Tests | 2 | 2018 | 526 | 0.260 |
Why?
|
Antiviral Agents | 2 | 2018 | 3070 | 0.260 |
Why?
|
Organ Transplantation | 1 | 2015 | 1178 | 0.240 |
Why?
|
Muscle Stretching Exercises | 1 | 2024 | 37 | 0.230 |
Why?
|
Liver | 4 | 2024 | 7578 | 0.200 |
Why?
|
Hepatorenal Syndrome | 1 | 2023 | 76 | 0.200 |
Why?
|
Meditation | 1 | 2024 | 257 | 0.180 |
Why?
|
Elasticity Imaging Techniques | 2 | 2024 | 398 | 0.180 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7478 | 0.170 |
Why?
|
Withholding Treatment | 2 | 2014 | 620 | 0.170 |
Why?
|
Clinical Competence | 1 | 2016 | 4860 | 0.170 |
Why?
|
Cholestasis | 1 | 2023 | 385 | 0.170 |
Why?
|
Cholagogues and Choleretics | 3 | 2024 | 39 | 0.170 |
Why?
|
Waiting Lists | 3 | 2023 | 779 | 0.160 |
Why?
|
Vasoconstrictor Agents | 1 | 2023 | 657 | 0.160 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2336 | 0.160 |
Why?
|
Th17 Cells | 2 | 2023 | 791 | 0.150 |
Why?
|
Apyrase | 1 | 2020 | 376 | 0.140 |
Why?
|
Refeeding Syndrome | 1 | 2017 | 16 | 0.140 |
Why?
|
Balloon Occlusion | 1 | 2017 | 131 | 0.140 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6982 | 0.130 |
Why?
|
Graft Survival | 2 | 2023 | 3888 | 0.120 |
Why?
|
Mass Screening | 1 | 2011 | 5457 | 0.120 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4363 | 0.120 |
Why?
|
Esophageal and Gastric Varices | 1 | 2017 | 215 | 0.120 |
Why?
|
Hepatitis | 1 | 2017 | 228 | 0.120 |
Why?
|
Venous Pressure | 1 | 2014 | 55 | 0.120 |
Why?
|
Esophageal Diseases | 1 | 2015 | 168 | 0.120 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12095 | 0.110 |
Why?
|
Portal Pressure | 1 | 2014 | 62 | 0.110 |
Why?
|
Acetaminophen | 1 | 2018 | 556 | 0.110 |
Why?
|
Hepatitis B e Antigens | 1 | 2014 | 135 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1143 | 0.110 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2014 | 113 | 0.110 |
Why?
|
Time Factors | 5 | 2023 | 40261 | 0.110 |
Why?
|
Recurrence | 5 | 2022 | 8513 | 0.110 |
Why?
|
Guanine | 1 | 2014 | 280 | 0.110 |
Why?
|
Middle Aged | 19 | 2024 | 223737 | 0.110 |
Why?
|
Humans | 38 | 2024 | 768970 | 0.110 |
Why?
|
Lamivudine | 1 | 2014 | 367 | 0.100 |
Why?
|
Drug Monitoring | 2 | 2018 | 965 | 0.100 |
Why?
|
Retrospective Studies | 12 | 2024 | 81903 | 0.100 |
Why?
|
Laparotomy | 1 | 2014 | 459 | 0.100 |
Why?
|
Fatigue | 1 | 2019 | 1557 | 0.090 |
Why?
|
Up-Regulation | 2 | 2020 | 4148 | 0.090 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15951 | 0.090 |
Why?
|
Colonic Polyps | 1 | 2016 | 557 | 0.090 |
Why?
|
Intestinal Diseases | 1 | 2015 | 505 | 0.090 |
Why?
|
Female | 21 | 2024 | 397515 | 0.090 |
Why?
|
Hepatitis C, Chronic | 1 | 2018 | 1033 | 0.090 |
Why?
|
Aged | 13 | 2024 | 171786 | 0.090 |
Why?
|
Malnutrition | 1 | 2017 | 632 | 0.090 |
Why?
|
Male | 20 | 2024 | 365203 | 0.080 |
Why?
|
Adult | 13 | 2024 | 223851 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2024 | 65480 | 0.080 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7861 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3438 | 0.080 |
Why?
|
Gastrointestinal Agents | 1 | 2014 | 510 | 0.080 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 877 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2015 | 1445 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1399 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3941 | 0.080 |
Why?
|
Adenine | 1 | 2014 | 995 | 0.080 |
Why?
|
Intracranial Hemorrhages | 1 | 2014 | 811 | 0.080 |
Why?
|
Risk Factors | 8 | 2023 | 74976 | 0.080 |
Why?
|
Boston | 2 | 2019 | 9377 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2258 | 0.070 |
Why?
|
Prognosis | 8 | 2024 | 30046 | 0.070 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 888 | 0.070 |
Why?
|
Intraoperative Complications | 1 | 2014 | 1176 | 0.070 |
Why?
|
Length of Stay | 2 | 2019 | 6526 | 0.070 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12562 | 0.070 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 1134 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3116 | 0.070 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4835 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6856 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6547 | 0.060 |
Why?
|
Tissue Donors | 1 | 2015 | 2382 | 0.060 |
Why?
|
Quality of Life | 2 | 2024 | 13510 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2784 | 0.060 |
Why?
|
Aspartate Aminotransferases | 2 | 2018 | 414 | 0.060 |
Why?
|
Venous Thrombosis | 1 | 2014 | 1321 | 0.060 |
Why?
|
Adenoma | 1 | 2016 | 2163 | 0.060 |
Why?
|
Patient Readmission | 2 | 2015 | 3313 | 0.060 |
Why?
|
Uridine | 1 | 2023 | 135 | 0.050 |
Why?
|
Bezafibrate | 1 | 2023 | 14 | 0.050 |
Why?
|
Streptococcus agalactiae | 1 | 2005 | 337 | 0.050 |
Why?
|
Hydrocarbons | 1 | 2023 | 105 | 0.050 |
Why?
|
Antipruritics | 1 | 2023 | 31 | 0.050 |
Why?
|
Lypressin | 1 | 2023 | 26 | 0.050 |
Why?
|
Kynurenine | 1 | 2023 | 142 | 0.050 |
Why?
|
Anticoagulants | 2 | 2015 | 4850 | 0.050 |
Why?
|
Biopsy | 1 | 2014 | 6805 | 0.050 |
Why?
|
Risk Assessment | 3 | 2019 | 24333 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13021 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2600 | 0.050 |
Why?
|
Ascites | 1 | 2022 | 338 | 0.040 |
Why?
|
Vibration | 1 | 2022 | 335 | 0.040 |
Why?
|
Alkaline Phosphatase | 1 | 2023 | 864 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2014 | 2442 | 0.040 |
Why?
|
Lipids | 1 | 2011 | 3345 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2022 | 348 | 0.040 |
Why?
|
Pruritus | 1 | 2023 | 379 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2023 | 1839 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 13055 | 0.040 |
Why?
|
North America | 1 | 2023 | 1290 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2022 | 39394 | 0.040 |
Why?
|
Prospective Studies | 4 | 2016 | 54962 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 859 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9264 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11879 | 0.040 |
Why?
|
Creatinine | 1 | 2023 | 1917 | 0.030 |
Why?
|
Immunomodulation | 1 | 2020 | 549 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2515 | 0.030 |
Why?
|
Water | 1 | 2022 | 1421 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2018 | 606 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10847 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2018 | 371 | 0.030 |
Why?
|
Disease Progression | 2 | 2024 | 13674 | 0.030 |
Why?
|
Cohort Studies | 4 | 2022 | 41808 | 0.030 |
Why?
|
beta-Alanine | 1 | 2014 | 82 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1560 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10400 | 0.030 |
Why?
|
Acute Disease | 2 | 2017 | 7245 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2014 | 513 | 0.030 |
Why?
|
Oxygen | 1 | 2005 | 4272 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3283 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2005 | 3702 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2023 | 2986 | 0.030 |
Why?
|
Stroke | 1 | 2014 | 9756 | 0.030 |
Why?
|
Drug Discovery | 1 | 2020 | 1068 | 0.030 |
Why?
|
Enoxaparin | 1 | 2014 | 391 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2017 | 5369 | 0.020 |
Why?
|
Morpholines | 1 | 2014 | 584 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2014 | 2298 | 0.020 |
Why?
|
Thiophenes | 1 | 2014 | 570 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4568 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2014 | 864 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2015 | 59739 | 0.020 |
Why?
|
Pyridones | 1 | 2014 | 819 | 0.020 |
Why?
|
Echocardiography | 1 | 2022 | 5047 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4207 | 0.020 |
Why?
|
Head | 1 | 2014 | 927 | 0.020 |
Why?
|
Thromboembolism | 1 | 2014 | 1004 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 8094 | 0.020 |
Why?
|
Emergencies | 1 | 2014 | 1221 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 5622 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2011 | 643 | 0.020 |
Why?
|
Young Adult | 1 | 2014 | 60131 | 0.020 |
Why?
|
Endoscopy | 1 | 2017 | 1862 | 0.020 |
Why?
|
Heparin | 1 | 2014 | 1636 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2011 | 682 | 0.020 |
Why?
|
Warfarin | 1 | 2014 | 1493 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 19023 | 0.010 |
Why?
|
Lung Diseases | 1 | 2014 | 1944 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2011 | 1820 | 0.010 |
Why?
|
Pyrazoles | 1 | 2014 | 2029 | 0.010 |
Why?
|
Bacterial Adhesion | 1 | 2005 | 305 | 0.010 |
Why?
|
Cause of Death | 1 | 2014 | 3721 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8055 | 0.010 |
Why?
|
Triglycerides | 1 | 2011 | 2464 | 0.010 |
Why?
|
United States | 2 | 2023 | 73186 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13318 | 0.010 |
Why?
|
RNA, Viral | 1 | 2011 | 2871 | 0.010 |
Why?
|
Patient Discharge | 1 | 2015 | 3491 | 0.010 |
Why?
|
Cell Polarity | 1 | 2005 | 639 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2403 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8894 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8748 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12873 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14794 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23653 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22296 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16731 | 0.010 |
Why?
|
Mice | 1 | 2023 | 82072 | 0.010 |
Why?
|
Coronary Disease | 1 | 2011 | 5919 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21547 | 0.010 |
Why?
|
Animals | 1 | 2023 | 169335 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20776 | 0.010 |
Why?
|
Concepts
(213)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_